S&P 500   4,550.77 (+0.40%)
DOW   35,156.19 (+0.36%)
QQQ   369.13 (+0.72%)
AAPL   166.71 (+0.29%)
MSFT   306.90 (+1.18%)
FB   322.16 (+0.80%)
GOOGL   2,717.76 (+0.57%)
AMZN   3,105.44 (-0.66%)
TSLA   1,018.85 (+2.33%)
NVDA   250.94 (+0.11%)
BABA   132.50 (+3.73%)
NIO   30.02 (+4.86%)
AMD   126.73 (-1.20%)
CGC   7.73 (+1.18%)
MU   87.77 (-2.48%)
GE   100.28 (-0.34%)
T   27.24 (-0.15%)
F   22.11 (-1.51%)
DIS   150.25 (+0.09%)
AMC   18.80 (+2.62%)
PFE   54.14 (+1.12%)
ACB   4.85 (-0.21%)
BA   218.12 (+0.48%)
S&P 500   4,550.77 (+0.40%)
DOW   35,156.19 (+0.36%)
QQQ   369.13 (+0.72%)
AAPL   166.71 (+0.29%)
MSFT   306.90 (+1.18%)
FB   322.16 (+0.80%)
GOOGL   2,717.76 (+0.57%)
AMZN   3,105.44 (-0.66%)
TSLA   1,018.85 (+2.33%)
NVDA   250.94 (+0.11%)
BABA   132.50 (+3.73%)
NIO   30.02 (+4.86%)
AMD   126.73 (-1.20%)
CGC   7.73 (+1.18%)
MU   87.77 (-2.48%)
GE   100.28 (-0.34%)
T   27.24 (-0.15%)
F   22.11 (-1.51%)
DIS   150.25 (+0.09%)
AMC   18.80 (+2.62%)
PFE   54.14 (+1.12%)
ACB   4.85 (-0.21%)
BA   218.12 (+0.48%)
S&P 500   4,550.77 (+0.40%)
DOW   35,156.19 (+0.36%)
QQQ   369.13 (+0.72%)
AAPL   166.71 (+0.29%)
MSFT   306.90 (+1.18%)
FB   322.16 (+0.80%)
GOOGL   2,717.76 (+0.57%)
AMZN   3,105.44 (-0.66%)
TSLA   1,018.85 (+2.33%)
NVDA   250.94 (+0.11%)
BABA   132.50 (+3.73%)
NIO   30.02 (+4.86%)
AMD   126.73 (-1.20%)
CGC   7.73 (+1.18%)
MU   87.77 (-2.48%)
GE   100.28 (-0.34%)
T   27.24 (-0.15%)
F   22.11 (-1.51%)
DIS   150.25 (+0.09%)
AMC   18.80 (+2.62%)
PFE   54.14 (+1.12%)
ACB   4.85 (-0.21%)
BA   218.12 (+0.48%)
S&P 500   4,550.77 (+0.40%)
DOW   35,156.19 (+0.36%)
QQQ   369.13 (+0.72%)
AAPL   166.71 (+0.29%)
MSFT   306.90 (+1.18%)
FB   322.16 (+0.80%)
GOOGL   2,717.76 (+0.57%)
AMZN   3,105.44 (-0.66%)
TSLA   1,018.85 (+2.33%)
NVDA   250.94 (+0.11%)
BABA   132.50 (+3.73%)
NIO   30.02 (+4.86%)
AMD   126.73 (-1.20%)
CGC   7.73 (+1.18%)
MU   87.77 (-2.48%)
GE   100.28 (-0.34%)
T   27.24 (-0.15%)
F   22.11 (-1.51%)
DIS   150.25 (+0.09%)
AMC   18.80 (+2.62%)
PFE   54.14 (+1.12%)
ACB   4.85 (-0.21%)
BA   218.12 (+0.48%)
NASDAQ:YTEN

Yield10 Bioscience Stock Forecast, Price & News

$3.96
-0.03 (-0.75%)
(As of 01/20/2022 10:33 AM ET)
Add
Compare
Today's Range
$3.96
$4.00
50-Day Range
$3.87
$6.08
52-Week Range
$3.76
$23.49
Volume
200 shs
Average Volume
55,394 shs
Market Capitalization
$19.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.25
30 days | 90 days | 365 days | Advanced Chart
Receive YTEN News and Ratings via Email

Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter.


Yield10 Bioscience logo

About Yield10 Bioscience

Yield10 Bioscience, Inc. operates as an agricultural bioscience company. It focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.

Headlines

Will Yield10 Bioscience (NASDAQ:YTEN) Spend Its Cash Wisely?
November 22, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Miscellaneous plastics products
Sub-Industry
N/A
Current Symbol
NASDAQ:YTEN
Employees
25
Year Founded
1992

Sales & Book Value

Annual Sales
$800 thousand
Book Value
$2.67 per share

Profitability

Net Income
$-10.21 million
Net Margins
-1,627.55%
Pretax Margin
-1,619.18%

Debt

Price-To-Earnings

Miscellaneous

Free Float
4,770,000
Market Cap
$19.33 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/09/2021
Today
1/20/2022
Next Earnings (Estimated)
3/15/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

1.86 out of 5 stars

Consumer Staples Sector

111th out of 184 stocks

Miscellaneous Plastics Products Industry

1st out of 1 stocks

Analyst Opinion: 3.5Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Yield10 Bioscience (NASDAQ:YTEN) Frequently Asked Questions

Is Yield10 Bioscience a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Yield10 Bioscience in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Yield10 Bioscience stock.
View analyst ratings for Yield10 Bioscience
or view top-rated stocks.

How has Yield10 Bioscience's stock been impacted by Coronavirus?

Yield10 Bioscience's stock was trading at $4.82 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, YTEN shares have decreased by 17.8% and is now trading at $3.96.
View which stocks have been most impacted by COVID-19
.

When is Yield10 Bioscience's next earnings date?

Yield10 Bioscience is scheduled to release its next quarterly earnings announcement on Tuesday, March 15th 2022.
View our earnings forecast for Yield10 Bioscience
.

How were Yield10 Bioscience's earnings last quarter?

Yield10 Bioscience, Inc. (NASDAQ:YTEN) posted its earnings results on Tuesday, November, 9th. The specialty chemicals company reported ($0.49) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.65) by $0.16. The specialty chemicals company had revenue of $0.09 million for the quarter, compared to analysts' expectations of $0.22 million. Yield10 Bioscience had a negative trailing twelve-month return on equity of 59.76% and a negative net margin of 1,627.55%. During the same quarter in the previous year, the firm earned ($0.87) EPS.
View Yield10 Bioscience's earnings history
.

When did Yield10 Bioscience's stock split? How did Yield10 Bioscience's stock split work?

Yield10 Bioscience's stock reverse split before market open on Thursday, January 16th 2020. The 1-40 reverse split was announced on Wednesday, January 15th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, January 15th 2020. An investor that had 100 shares of Yield10 Bioscience stock prior to the reverse split would have 3 shares after the split.

What price target have analysts set for YTEN?

1 brokerages have issued 1-year price objectives for Yield10 Bioscience's stock. Their forecasts range from $24.00 to $24.00. On average, they expect Yield10 Bioscience's share price to reach $24.00 in the next twelve months. This suggests a possible upside of 506.1% from the stock's current price.
View analysts' price targets for Yield10 Bioscience
or view top-rated stocks among Wall Street analysts.

Who are Yield10 Bioscience's key executives?

Yield10 Bioscience's management team includes the following people:
  • Oliver P. Peoples, President, Chief Executive Officer & Director
  • Charles B. Haaser, Chief Accounting Officer, Treasurer & VP-Finance (LinkedIn Profile)
  • Kristi D. Snell, Chief Science Officer & Vice President-Research
  • Nicholas Renegar, Director-Business Analytics & Operations
  • Lynne H. Brum, Secretary, VP-Planning & Communications

What other stocks do shareholders of Yield10 Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Yield10 Bioscience investors own include KushCo (KSHB), (CGC), OPKO Health (OPK), T2 Biosystems (TTOO), FuelCell Energy (FCEL), TherapeuticsMD (TXMD), Viking Therapeutics (VKTX), Rigel Pharmaceuticals (RIGL), (SCON) and Advanced Micro Devices (AMD).

What is Yield10 Bioscience's stock symbol?

Yield10 Bioscience trades on the NASDAQ under the ticker symbol "YTEN."

How do I buy shares of Yield10 Bioscience?

Shares of YTEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Yield10 Bioscience's stock price today?

One share of YTEN stock can currently be purchased for approximately $3.96.

How much money does Yield10 Bioscience make?

Yield10 Bioscience has a market capitalization of $19.33 million and generates $800 thousand in revenue each year. The specialty chemicals company earns $-10.21 million in net income (profit) each year or ($2.52) on an earnings per share basis.

How many employees does Yield10 Bioscience have?

Yield10 Bioscience employs 25 workers across the globe.

When was Yield10 Bioscience founded?

Yield10 Bioscience was founded in 1992.

What is Yield10 Bioscience's official website?

The official website for Yield10 Bioscience is www.yield10bio.com.

Where are Yield10 Bioscience's headquarters?

Yield10 Bioscience is headquartered at 19 PRESIDENTIAL WAY, WOBURN MA, 01801.

How can I contact Yield10 Bioscience?

Yield10 Bioscience's mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The specialty chemicals company can be reached via phone at (617) 583-1700, via email at [email protected], or via fax at 617-583-1768.


This page was last updated on 1/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.